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Enhanced Survival and Regeneration of Axotomized Retinal
Ganglion Cells by a Mixture of Herbal Extracts
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ABSTRACT
The aim of this study is to investigate the effects of Panax quinquefolius L. extract (PQE), Ginkgo
biloba extract (GBE), and Hypericum perforatum extract (HPE), in combination or alone, on the sur-
vival and regeneration of axotomized retinal ganglion cells (RGCs) in an optic nerve transection
model in adult hamsters. Unilateral transection of the optic nerve was performed to evaluate the ef-
fects of herbal extracts on the survival of axotomized RGCs. Effects of the herbal extracts on ax-
onal regeneration of axotomized RGCs, on the other hand, were studied by attaching a peripheral
nerve graft onto the transected ocular stump to induce regeneration. Operated animals received
daily oral administration of vehicle or herbal extracts (PQE, GBE, and HPE), alone or in combi-
nation, for 7 and 21 days, respectively, in the survival and regeneration experiments. Surviving and
regenerating RGCs were retrogradely labeled with Fluoro-Gold. The eyes were then enucleated and
the retinas were flat-mounted for the counting of the labeled RGCs. Treatment with PQE, GBE and
HPE alone failed to offer neuroprotection to injured RGCs. However, treatment with Menta-FX, a
mixture of PQE, GBE, and HPE, significantly augmented RGC survival 7 days postaxotomy. Treat-
ment with Menta-FX also induced a significant (87%) increase in the number of regenerating RGCs
21 days after optic nerve transection. This study demonstrates that herbs can act as a potential neu-
roprotective agent for damaged RGCs. It also suggests that the therapeutic value of herbal reme-
dies can be maximized by the use of mixtures of appropriate herbs.
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INTRODUCTION
TRANSECTION OF THE OPTIC NERVE in adult rats inducesneuronal death in approximately 80% of the retinal
ganglion cells (RGCs) in 14 days (Villegas-Perez et al.,
1993; Peinado-Ramon et al., 1996; Berkelaar et al.,
1994). It was proposed that the retrograde degeneration
of axotomized RGCs is due to a lack of trophic factor
supply upon disconnection from their target sites. This
view is supported by experiments showing trophic fac-
tors, including BDNF (Yan et al., 1999; Isenmann et al.,
1998; Peinado-Ramon et al., 1996; Di Polo et al., 1998);
GDNF (Yan et al., 1999); CNTF (Mey and Thanos, 1993;
Yip et al., 2000); NGF (Lambiase et al., 1997; Rabacchi
et al., 1994b); and NT4/5 (Peinado-Ramon et al., 1996;
Yip and So, 2000) are able to delay RGC death follow-
ing axotomy. Recent evidence has attributed the death of
axotomized RGCs to apoptosis (Kermer et al., 1999b;
Rabacchi et al., 1994a; Garcia-Valenzuela et al., 1994).
Interruption of the apoptotic pathway with agents like
caspase inhibitor z-DEVD-cmk (Kermer et al., 1998,
1999a) or overexpression of bcl-2 in transgenic mice
(Cenni et al., 1996; Porciatti et al., 1996; Bonfanti et al.,
1996) augment the survival of axotomized RGCs. Ox-
idative stress has been implicated as one of the potent in-
ducers and modulators of the apoptotic pathway in is-
chemia (Keller et al., 1998) and NMDA-induced retinal
toxicity (Vorwerk et al., 1997; Castagne et al., 1999).
Thus, it is not unreasonable to speculate that antioxidants
may offer neuroprotection to axotomized RGCs. In sup-
port of this hypothesis, intravitreal injections of the 
nitric oxide synthase (NOS) inhibitors, L-NAME and 
L-NOLA, enhance the survival of RGCs following axo-
tomy (Ball and Keoberle, 1999). These observations sug-
gest that free radicals play a role in the etiology of axo-
tomized RGC death, and thus, free radical scavengers
may be neuroprotective for axotomized RGCs.
Extracts from American ginseng (Panax quinquefolius
L.; Kitts et al., 2000), Ginkgo biloba (Baudouin et al.,
1999; Wei et al., 2000; Bastianetto et al., 2000a) and 
St. John’s Wort (Hypericum perforatum; Tripathi and
Pandey, 1999) have been demonstrated to exhibit an-
tioxidant properties. In addition, these herbal extracts ap-
pear to offer neuroprotection in other models of injury.
For example, saponins of Panax quinquefolius L. have
been shown to delay neuronal death during ischemia (At-
tele et al., 1999; Wen et al., 1996) and glutamate-induced
excitotoxicity (Kim et al., 1998). Ginkgo biloba has also
been observed to protect against ischemic injury (Pierre
et al., 1999), b-amyloid–induced toxicity (Bastianetto et
al., 2000a), nitric oxide–induced toxicity (Bastianetto et
al., 2000b), MPTP-induced nigrostriatal neuronal death
(Wu and Zhu, 1999), and light-induced photoreceptor
damage (Ranchon et al., 1999). Taken together, these
studies suggest that Ginkgo biloba, Panax quinquefolius
L., and Hypericum perforatum extracts may have neuro-
protective effects in axotomy-induced RGC death. In the
current communication, we examine the effects of these
extracts, alone or in combination, on the survival of ax-
otomized RGCs in adult hamsters. Since robust regener-
ation of damaged axons also requires survival of the
parental neurons, agents that increase viability of axo-
tomized RGCs may also promote the regrowth of their
axons. Accordingly, we also investigate the effects of
these herbal extracts on the capacity of axotomized RGCs
to regenerate into a peripheral nerve graft, which pro-
vides a permissive environment for axonal regeneration
(So and Aguayo, 1985).
MATERIALS AND METHODS
Animals
A total of 112 adult golden hamsters (Mesocricetus au-
ratus, 6–8 weeks old, weighing 60–80 g) were used in
this study. Golden hamsters have been used in studies in
which peripheral nerve grafts are attached to the ocular
stump to induce long-distance regeneration (So and Yip,
2001; Cui et al., 1999). The ability of the regenerated ax-
ons to form functional synapses has also been demon-
strated by connecting the peripheral nerve grafts to tar-
gets such as the superior colliculus (Sauve et al., 2001;
Sasaki et al., 1999). Specific tests utilizing the orienting
behavior exhibited by hamsters can then be performed to
accurately examine functional recovery following axo-
tomy (Carman and Schneider, 1992; Schneider, 1969).
The use of golden hamsters in this study therefore allows
future investigation of the herbal extracts’ ability to aug-
ment and restore visual performances. All operations
were carried out in animals anesthetized with intraperi-
toneal injection of sodium pentobarbitone (Nembutal,
Rhone Merieux Australia Pty Ltd., Australia; 50 mg/kg).
Animals were weighed on the day of operation and on
the day of sacrifice. The incidence of diarrhea and acute
weight loss were monitored as indicators of the herbal
extracts potential side effects as adverse reactions such
as gastrointestinal problems, diarrhea and acute weight
loss have been associated with HPE or PQE intake (Ernst
et al., 1998; Vogler et al., 1999). All animals were sac-
rificed with an overdose of anesthesia.
Extracts
Herbal extracts from CV Technologies (Canada, Ed-
monton, Alberta) were used in this study. The extracts
were standardized by their biological activities and chem-
ical compositions using ChemBioPrint™ technology, en-
suring batch-to-batch consistency. Three extracts were
used: (1) extract from the root of Panax quinquefolius L.
(PQE), standardized to contain 25% ginsenosides; (2)
Ginkgo biloba extract (GBE), standardized to contain
24% flavonoid glycosides and 6% terpenoids; and (3) Hy-
pericum perforatum extract (HPE), standardized to con-
tain 0.3% hypericin. Two herbal mixtures were con-
structed from these standardized extracts: (1) AD-FX,
consisted of 80% PQE and 20% GBE by weight; and (2)
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Menta-FX, composed of 30.8% PQE, 61.5% HPE and
7.7% GBE by weight. All herbal potions (single extracts
or mixtures) were suspended in sterile 0.01 M phosphate-
buffered saline (PBS; pH 7.4) at concentrations specified
in the following section, stored at 4°C and administered
to animals within 2 weeks. The extracts were delivered
directly into the esophagus of the animals with a spe-
cialized feeding cannula.
Herbal Extracts Treatment Scheme
In the survival studies, animals were divided into three
groups: control (0.01 M PBS, n 5 10), single extracts
treatment (n 5 53), and extract-mixtures treatment (n 5
21). Refer to Table 1 for detailed description of the treat-
ment groups. Briefly, the single extract treatment group
was divided into three subgroups. Animals received ei-
ther PQE (10, 20, or 30 mg), GBE (2, 6, or 12 mg), or
HPE (10, 20, and 30 mg). The extract-mixture treatment
group was divided into two subgroups: 30 mg AD-FX
and 30 mg Menta-FX. Animals were fed daily with 0.5
mL of vehicle or herbal extracts starting on the day of
operation for 7 days. Animals were allowed to survive
for 7 days postaxotomy before they were sacrificed.
In the regeneration studies (n 5 23), animals were di-
vided into four groups (Table 1). Animals were fed with
0.5 mL of vehicle (0.01 M PBS), 30 mg PQE, 30 mg
AD-FX, or 30 mg Menta-FX per day for 21 days, start-
ing on the day of operation. Animals were allowed to sur-
vive for 21 days postgrafting before they were sacrificed.
Optic Nerve Transection and Attachment of
Peripheral Nerve Graft
In the survival studies (n 5 84), unilateral optic nerve
transection was performed. A skin incision was made
close to the superior orbital rim of the left eye. The left
orbita was exposed and the superior extraocular muscles
were excised to uncover the optic nerve. After opening
the dural sheath, the optic nerve was completely tran-
sected at about 1.5 mm from the optic disc.
In the regeneration studies, an autologous peripheral
nerve (PN) graft was attached to the ocular stump as a
conduit for axonal regeneration. The optic nerve was tran-
sected 0.5 mm from the optic disc. A segment of the sci-
atic nerve (1 cm) was sutured onto the proximal stump
of the optic nerve with a 10/0 suture. The distal end of
the PN graft was secured on the connective tissue of the
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TABLE 1. TREATMENT PARADIGM EMPLOYED TO INVESTIGATE THE EFFECTS OF PQE, HPE, AND GBE ALONE
OR IN COMBINATION ON THE SURVIVAL AND REGENERATION OF AXOTOMIZED RGCS
Experiment Groups PQE (mg) GBE (mg) HPE (mg) No. of animals
Survival
Control (PBS) 10
PQE single extract
10 6
20 6
30 9
GBE single extract
2 5
6 5
12 5
HPE single extract
10 6
20 6
30 5
Extract-mixtures
30 mg AD-FX 24 6 10
30 mg Menta-FX 9.23 2.31 18.46 11
Regeneration
Control (PBS) 6
PQE single extract 30 6
30 mg AD-FX 24 6 6
30 mg Menta-FX 9.23 2.31 18.46 5
The respective amount of each of the single extracts in 30 mg of AD-FX and Menta-FX is listed.
skull using a 5/0 suture (So and Aguayo, 1985). Care was
taken to keep the blood supply to the retina intact
throughout the operations. Animals with compromised
blood supply after the operation were discarded.
Retrograde Labeling of Retinal Ganglion Cells
and Labeled Retinal Ganglion Cells Counts
To assess the number of RGCs in normal retina, the
optic nerve was transected in five animals. A Gelfoam
(Upjohn, Kalamazoo, MI) soaked with 6% Fluoro-Gold
(FG; Fluorochrome, Denver, CO) was placed at the cut
site immediately after transection to label the RGCs. The
animals were sacrificed 2 days later. Since optic nerve
transection results in delayed cell death beginning on day
4 after axotomy (Berkelaar et al., 1994), the number of
RGCs labeled was assumed to be representative of the
number of RGCs present in normal retinas.
In the survival studies, surviving RGCs were retro-
gradely labeled by placing a Gelfoam soaked with 6% FG
at the ocular stump 2 days before sacrificing the animals.
In the regeneration experiment, regenerating RGCs were
labeled by injecting 1.5 mL of 6% FG into the distal end
of the PN graft 3 days before the animals were killed. The
left eye of the euthanatized animals in the normal, survival,
and regeneration groups were enucleated, and the retinas
dissected in 4% paraformaldehyde (PFA). Four radial cuts
were made to divide the retinas into four quadrants (supe-
riotemporal, superionasal, inferiotemporal and inferi-
onasal). The retinas were then postfixed in 4% PFA for 45
min before they were flat-mounted with the RGC side up
on gelatin-coated slides in 30% glycerin.
The slides were examined under fluorescence mi-
croscopy using an ultra-violet filter (excitation wave-
length5 330–380 nm). Labeled RGCs were counted
along the median line of the four quadrants starting from
the optic disc to the peripheral border of the retina at 500
mm intervals, under an eyepiece grid of 2003 200 mm.
The mean density of labeled RGCs in each retina was
then multiplied by the area of the retina to obtain the
number of labeled RGCs in the retina.
All data were expressed as mean6 SD. Statistical sig-
nificance was evaluated by one way ANOVA, followed
by Tukey-Kramer post hoc test. Differences were con-
sidered significant for p , 0.05. Retinas that were poorly
labeled were excluded from statistical analysis.
RESULTS
Effects of Optic Nerve Transection on the
Number of Retinal Ganglion Cells
The number of RGCs labeled in normal retina was
65,8906 5,684. Optic nerve transection led to a marked
decrease in the number of surviving RGCs 7 days after
axotomy in the PBS-treated group (21,8416 3,536; Fig.
1). The morphology of the labeled RGCs was in accor-
dance with that observed in previous studies (Peinado-
Ramon et al., 1996; Koeberle and Ball, 1998). FG fluo-
rescence was found in the somata and proximal dendrites
of the RGCs (Fig. 2A). In addition to the labeled RGCs,
microglia, characterized by their small spindle-shaped
soma could also be identified (arrowhead, Fig. 2A).
Effects of Single Extracts of PQE, GBE, and
HPE on the Survival of Axotomized Retinal
Ganglion Cells
Oral administration of PQE, GBE, and HPE for 7 days
did not adversely affect the animals well-being. No diar-
rhea or acute weight loss was observed (data not shown).
For the three dosages of PQE examined, treatment with
10 mg (23,9996 3,099), 20 mg (23,6346 6,659), or 30
mg (23,9846 6,362) daily for 7 days had negligible 
effects on axotomized RGC survival (Fig. 1). Daily 
administration of 10 mg (21,7356 3,074), 20 mg
(23,9286 4,841), and 30 mg of HPE (25,0446 2,634)
resulted in slight enhancement of the number of surviv-
ing RGCs that appeared to be dose-related. The increase,
however, was not significant (Fig. 1). Treatment with 2
mg (24,4346 1,692), 6 mg (23,0656 3,883), and 12 mg
of GBE (24,8616 4,167) similarly did not significantly
augment the number of surviving RGCs at 7 days after
axotomy (Fig. 1).
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FIG. 1. Effects of Panax quinquefolius L. extract (PQE; 10,
20, and 30 mg), Ginkgo biloba extract (GBE; 2, 6, and 12 mg),
and Hypericum perforatum extract (HPE; 10, 20, and 30 mg)
on the survival of axotomized retinal ganglion cells 7 days af-
ter axotomy. Note that none of the treatment significantly af-
fected the number of surviving cells compared with that of the
PBS-treated optic nerve transection (ONT) group.
Effects of AD-FX and Menta-FX on the Survival
of Axotomized Retinal Ganglion Cells
No adverse reaction was observed following oral ad-
ministration of AD-FX and Menta-FX for 7 days, with
no incidence of diarrhea or acute weight loss (data not
shown). Treatment with 30 mg of AD-FX per day (Fig.
2C) caused a slight increase in the number of surviving
RGCs (27,0346 4,268; Fig. 3), although the enhance-
ment was not statistically significant. However, daily
treatment with 30 mg of Menta-FX (Fig. 2D) significantly
augmented the number of surviving RGCs (30,3856
6,187; Fig. 3), rescuing 19% of the RGCs that would have
died without treatment (p , 0.01; one-way ANOVA).
Rescue rate was estimated by the following formula: [(no.
of RGCs in treatment group2 no. of RGCs in ONT
group)/(no. of RGCs in normal retina2 no. of RGCs in
ONT group)]3 100. Administration of PQE, HPE, and
GBE individually had negligible effects on axotomized
RGC survival, in contrast to the significant neuroprotec-
tion provided by a mixture of the three at equivalent
dosages.
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FIG. 2. Photomicrographs of FG-labeled RGCs taken from retina treated with vehicle (A) or herbal extracts (B–D) at compa-
rable distance from the optic disc. (A) Seven days after optic nerve transection, very few labeled RGCs remained. Notice the
presence of microglia (arrowhead), which is characterized by a spindle-shaped somata. (B) Treatment with 30 mg of PQE daily
for 7 days has negligible effect on the number of labeled RGCs. (C) Treatment with AD-FX (30 mg/day) again has limited neu-
roprotective effect on the axotomized RGCs. (D) Treatment with Menta-FX (30 mg/day) lead to a marked increase in the num-
ber of surviving RGCs 7 days post axotomy. Bar 5 25 mm.
FIG. 3. Effects of herbal extracts mixtures on the survival of
axotomized retinal ganglion cells 7 days after axotomy. Note
that while equivalent dosages of PQE, GBE, and HPE failed to
increase the number of surviving cells, Menta-FX (a mixture
of the three), offered significant neuroprotection. *p , 0.01 ver-
sus optic nerve transection (ONT).
Effects of PQE, AD-FX, and Menta-FX on
Regeneration of Axotomized Retinal Ganglion
Cells into Peripheral Nerve Graft
Attachment of PN graft to the optic nerve stump
elicited approximately 5% of the RGCs to regrow their
axons into the PN graft 21 days after axotomy (3,3016
1,192; see Fig. 5 below). As seen in Figure 4A, regener-
ating RGCs exhibited a characteristic hypertrophic mor-
phology (Cui et al., 1999) that was drastically different
from the surviving RGCs observed in Figure 2A. Treat-
ment with 30 mg/day PQE (3,7026 637) and 30 mg/day
AD-FX (4,6586 1,348) had no significant effects on the
regenerative capability of the axotomized RGCs. Treat-
ment with Menta-FX (Fig. 4D), however, led to a sig-
nificant increase in number of regenerating RGC
(6,1746 1,966; Fig. 5). This is a 87% enhancement in
the number of regenerated RGCs compared with control
(p , 0.05, one-way ANOVA).
DISCUSSION
In this study, we examined the effects of herbal ex-
tracts on axotomized RGCs. Our data showed that neg-
ligible neuroprotection was offered by PQE, GBE, and
HPE treatment, despite previously demonstrated free rad-
ical scavenging capacity of the extracts in earlier studies.
The apparent lack of action by these extracts could be
due to poor absorption of extract components, although
earlier studies suggest that HPE and GBE are well ab-
sorbed after ingestion (Franklin et al., 1999; Ranchon et
al., 1999). In addition, previous studies using oral ad-
ministration of Panax quinquefolius L. saponins and
EGb761 (a Ginkgo biloba extract) have shown that there
is significant neuroprotection of damaged neurons in vivo
(Wen et al., 1996; Pierre et al., 1999; Baudouin et al.,
1999; Ranchon et al., 1999), implying that the extracts
components were absorbed and remained active.
Insufficient amounts of extract metabolites reaching
the eye and/or the injury site may also result in the lack
of neuroprotection by single extracts. The concentration
of extract components required at the site of injury to res-
cue damaged neurons can vary depending on the type of
injury and neuronal subtypes. For example, previous
studies using lower doses of GBE than that adopted in
the current study have been shown to provide effective
neuroprotection in light-damaged photoreceptors (Ran-
chon et al., 1999) and ischemic cortical neurons (Pierre
et al., 1999). Despite the higher doses of GBE used in
the present study, no protective effect was observed.
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FIG. 4. Photomicrographs of FG-labeled RGCs taken from retina treated with vehicle (A) or herbal extracts (B–D) at compa-
rable distance from the optic disc. (A) Twenty-one days after peripheral nerve graft attachment, about 5% of the RGCs extended
their axons. (B) Treatment with 30 mg of PQE daily for 21 days has negligible effect on the number of regenerated RGCs. (C)
Treatment with AD-FX (30 mg/day) again has no effect on the regenerative capacity of the axotomized RGCs. (D) Treatment
with Menta-FX (30 mg/day) lead to a marked increase in the number of regenerating RGCs 21 days postgrafting. Bar 5 25 mm.
Therefore, it is possible that a higher concentration of an-
tioxidants is needed at the site of injury to protect RGCs
from axotomy-induced death.
Other factors contributing to the lack of neuroprotec-
tion by single extracts may include the low concentration
or absence of antioxidative ingredients in the extract
preparations used in this study. The amount of active
components in a herbal extract can vary depending on
the strain of the herbs used. Different strains of ginseng,
for example, have been demonstrated to contain differ-
ent amounts of various ginsenosides (Chan et al., 2000;
Wang et al., 1999). The PQE preparation used in this
study may hence lack or contain lower concentrations of
various ginsenosides isolated from Panax ginseng, which
have been demonstrated to be neuroprotective against is-
chemia (Attele et al., 1999; Wen et al., 1996) and gluta-
mate-induced excitotoxicity (Kim et al., 1998) in neu-
rons.
Finally, the treatment paradigm employed can also af-
fect the effectiveness of the herbal extracts. Some of the
previous studies with Ginkgo biloba extract involved pre-
treatment or co-treatment of the damaged neurons. How-
ever, in this study, treatment with PQE, HPE, and GBE
did not commence until at least 2 h after the damage had
been inflicted. This difference may contribute to the ob-
served lack of neuroprotective effect of single extracts on
axotomized RGCs. It should be noted, however, that stud-
ies by Bastianetto et al. have shown that post-injury treat-
ment with EGb 761 can rescue neurons from nitric ox-
ide–induced cell death (Bastianetto et al., 2000b) and
b-amyloid–induced toxicity (Bastianetto et al., 2000a).
The time frame in which treatment need to commence
may vary with the type of damage and neuronal subtypes.
Experiments using a pretreatment paradigm will be help-
ful in resolving this problem.
A significant finding of this study is the neuroprotec-
tive effect exhibited by Menta-FX. The observation that
the herbal extracts were only effective in combination
suggests that the therapeutic values of herbal extracts can
be maximized by mixing appropriate herbs together. In-
deed, potency of a herbal remedy is often increased by
using the whole extract, including the active ingredients
and the supposedly inactive ingredients. For example, a
study by Wu and Zhu (1999) has shown that EGb 761
prevents the decrease in dopamine levels in striatum fol-
lowing MPTP injection while the isolated compounds of
EGb 761, ginkgolides A and B, do not. In addition, only
ginseng extract can protect against ischemic neuronal
death in gerbils, with ginsenosides Rb1, Rg1, and R0 be-
ing less effective or having no effects at all on mitigat-
ing the damage (Wen et al., 1996).
The mechanisms involved in the neuroprotective ef-
fects of Menta-FX remain unknown. The neuroprotective
property of Menta-FX may be a manifestation of the sum-
mation of free radical scavenging abilities of the differ-
ent extracts. This is unlikely, however, given that high
doses of PQE, GBE and HPE failed to provide equiva-
lent neuroprotection offered by Menta-FX. On the other
hand, Menta-FX may provide other neuroprotective prop-
erties aside from anti-oxidative capacity. Other potential
mechanisms include (1) generation of novel neuropro-
tective compounds via chemical reactions among the in-
gredients of the extracts and (2) active compounds in the
different extracts may act on different components of the
apoptotic pathway involved in the death of axotomized
RGCs. Menta-FX may directly inhibit activation of cas-
pase-3 or -9, which have been demonstrated in axo-
tomized RGCs (Kermer et al., 1999b). Menta-FX may
also offer neuroprotection by up-regulating production of
trophic factors shown to enhance survival of axotomized
RGCs, such as BDNF or CNTF (Yan et al., 1999; Isen-
mann et al., 1998; Peinado-Ramon et al., 1996; Di Polo
et al., 1998; Mey and Thanos, 1993). It is difficult to
identify the pathways involved in the rescue effect of
Menta-FX since the pharmacology of these extracts on
injured neurons has not been completely elucidated.
However, our observations suggest that two factors may
play a role in Menta-FX’s neuroprotective property. Note
that AD-FX, a mixture of PQE and GBE, differs from
Menta-FX, a mixture of PQE, HPE, and GBE, by the ex-
clusion of HPE. The lack of significant rescue effect by
AD-FX may suggest that (1) HPE is essential for the neu-
roprotective property of Menta-FX; or (2) all three of the
extracts are required for the neuroprotective capability
observed in Menta-FX. It remains to be clarified whether
other combinations of the three herbal extracts such as
HPE and GBE; or PQE and HPE, contribute to the neu-
roprotective effects of Menta-FX.
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FIG. 5. Effects of Panax quinquefolius L. extract (PQE), AD-
FX, and Menta-FX on the number of regenerating RGCs into
attached peripheral nerve graft. *p , 0.05 versus control.
In this study, treatment with PQE and AD-FX had neg-
ligible effects on the regeneration of axotomized RGCs.
Treatment with Menta-FX, on the other hand, almost dou-
bled the number of regenerating RGCs compared to that
from the PBS-treated group (9.4% versus 5% of total
RGCs). The mechanisms underlying Menta-FX’s ability
to augment regeneration of RGCs into a peripheral nerve
graft are possibly related to its capacity to rescue axo-
tomized RGCs. CNTF (Mey and Thanos, 1993; Yip et
al., 2000; Cui et al., 1999) and aurintricarboxylic acid
(Heiduschka and Thanos, 2000) have been demonstrated
recently to enhance both survival and regeneration of ax-
otomized RGCs. Similarly, Menta-FX may promote re-
generation by increasing the number of surviving cells,
hence permitting the regeneration-sensitive subpopula-
tions of RGCs to survive long enough to extend their ax-
ons. PQE and AD-FX, which failed to significantly mit-
igate axotomy-induced RGC death also lacked the ability
to enhance regeneration of axotomized RGCs. On the
other hand, Menta-FX may also augment regeneration by
modulating other parameters known to affect regenera-
tive capacity. For example, Menta-FX may upregulate the
expressions of proteins such as GAP-43, which was
shown to precede robust regeneration of transected ax-
ons (Ng et al., 1995). Menta-FX may also promote the
synthesis of cytoskeletal components in axotomized
RGCs to allow effective regeneration. In addition, it may
change the behavior of growth cones to favor long-dis-
tance regeneration over limited local sprouting. Extrinsi-
cally, Menta-FX may neutralize the inhibitory environ-
ment surrounding the growing axons, such as the glial
scar, to enable efficient regrowth of the axons (Grill and
Tuszynski, 1999). However, the precise actions of Menta-
FX on these pathways remain to be uncovered by further
experimentation.
In conclusion, the potential use of herbal extracts as
neuroprotective agents for the injured RGCs is encour-
aging. Herbal extracts can be taken orally and possess
minimal side effects. This is a significant advantage com-
pared to drugs that are effective only when administered
via an invasive route. In addition, the effectiveness of
Menta-FX as a neuroprotective agent may be further in-
creased by modifying the dosage used or the proportion
of PQE, GBE and HPE in the mixture. Recent findings
from our lab show that higher doses of Menta-FX fur-
ther enhance the number of surviving RGCs at various
time-points following axotomy. In addition, the duration
of significant neuroprotection offered by Menta-FX can
be extended using higher doses (unpublished observa-
tions). This suggests possible long-term neuroprotection
by the herbal mixture.
This study holds important implications on the ap-
proach to take to enhance the therapeutic values of herbal
extracts in neurodegenerative diseases or central nervous
system trauma. We have demonstrated that a herbal ex-
tract-mixture exhibits neuroprotective effects on axo-
tomized RGCs and increases regenerative propensity of
the damaged axons. In addition, we showed that the ther-
apeutic capacity of the herbal extracts is significantly
augmented by using mixtures of the herbal extracts. We
have established an easily-accessible and reproducible
model for further investigations of the neuroprotective ef-
fect of these herbs. Fully explicating the precise interac-
tion of these herbs will increase our understanding of the
herbs and the mechanisms involved in the death & sur-
vival of axotomized RGCs.
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